Analytical Data
-
Gene name
WDFY1
- Application
-
Alternative Names
(FYVE domain-containing protein localized to endosomes 1)(FENS-1)(Phosphoinositide-binding protein 1)(WD40- and FYVE domain-containing protein 1)(Zinc finger FYVE domain-containing protein 17)
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IWB7
-
Expression Region
1-410aa
-
Molecular Weight
53.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WDFY1 (WD repeat and FYVE domain containing 1) is a protein that plays a pivotal role in various cellular processes, including endocytosis, autophagy, and immune response regulation. Recent research has highlighted its significance in the context of several diseases, particularly in the immune system, where mutations or dysregulation of WDFY1 have been linked to autoimmune disorders and immunodeficiencies. Given its functional importance, the investigation of recombinant WDFY1 protein has gained momentum, aiming to elucidate its precise mechanisms of action and interactions at the molecular level. The production of recombinant WDFY1 allows for detailed studies, including structural analysis, interaction mapping, and functional assays, which are essential for understanding its role in cellular pathways. Furthermore, elucidating the biophysical properties of WDFY1 may pave the way for potential therapeutic interventions targeting its dysregulation in various diseases. Researchers are focusing on optimizing expression systems and purification methods to generate biologically active recombinant WDFY1, facilitating further studies that could uncover novel insights into its biological functions and clinical relevance.
This multifaceted approach not only enhances our understanding of WDFY1 but also opens avenues for developing diagnostic and therapeutic tools, ultimately contributing to advances in precision medicine for conditions associated with WDFY1 dysfunction. As the research progresses, insights garnered from recombinant WDFY1 studies could significantly impact therapeutic strategies, particularly in the realm of immune-related diseases.
